Aperio Group’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $1.58M | Buy |
18,851
+2,926
| +18% | +$245K | ﹤0.01% | 1347 |
|
|
2020
Q3 | $571K | Buy |
15,925
+5,772
| +57% | +$207K | ﹤0.01% | 1743 |
|
|
2020
Q2 | $245K | Buy |
+10,153
| New | +$245K | ﹤0.01% | 2103 |
|
|
2019
Q3 | – | Sell |
-667
| Closed | -$14K | – | 2434 |
|
|
2019
Q2 | $14K | Buy |
+667
| New | +$14K | ﹤0.01% | 2739 |
|